• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本癌症患者中铜和铂类药物外排转运蛋白 ATP7A 和 ATP7B 的遗传多态性。

Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients.

机构信息

Project team for Pharmacogenetics, National Institute of Health Sciences, Tokyo 158-8501, Japan.

出版信息

Drug Metab Pharmacokinet. 2009;24(6):565-74. doi: 10.2133/dmpk.24.565.

DOI:10.2133/dmpk.24.565
PMID:20045993
Abstract

ATP7A and ATP7B are involved in cellular resistance to platinum compounds such as cisplatin. By sequencing ATP7A, 38 genetic variations, including 30 novel ones were detected from 203 Japanese cancer patients. Of these, seven nonsynonymous variations were found: novel 1030A>G (R344G), 2111A>G (Q704R), 2200C>A (Q734K), 2948C>T (T983M) and 3112G>A (V1038I) at 0.004 frequencies and known 2299G>C (V767L) and 4390A>G (I1464V) at 0.351 and 0.075 frequencies, respectively. Regarding ATP7B, 28 novel and 33 known genetic variations were detected including 13 nonsynonymous ones: novel 1258A>G (M420V), 1426G>A (A476T), and 2401A>C (T801P) were found at 0.002, 0.005, and 0.002, respectively and known 1216G>T (A406S), 1366G>C (V456L), 2495A>G (K832R), 2785A>G (I929V), 2855G>A (R952K), 2871delC (P957PfsX9), 3419T>C (V1140A), 3836A>G (D1279G), 3886G>A (D1296N) and 3889G>A (V1297I) at 0.483, 0.463, 0.387, 0.005, 0.384, 0.005, 0.387, 0.002, 0.012, and 0.015 frequencies, respectively. Linkage disequilibrium between detected variations was also analyzed. Our results would provide fundamental and useful information for genotyping ATP7A and ATP7B in the Japanese and probably other Asian populations.

摘要

ATP7A 和 ATP7B 参与细胞对顺铂等铂类化合物的耐药性。通过对 ATP7A 的测序,从 203 名日本癌症患者中检测到 38 种遗传变异,包括 30 种新的变异。其中,发现 7 种非同义变异:新的 1030A>G(R344G)、2111A>G(Q704R)、2200C>A(Q734K)、2948C>T(T983M)和 3112G>A(V1038I),频率分别为 0.004、0.004、0.004、0.004 和 0.004,已知的 2299G>C(V767L)和 4390A>G(I1464V)的频率分别为 0.351 和 0.075。关于 ATP7B,检测到 28 种新的和 33 种已知的遗传变异,包括 13 种非同义变异:新的 1258A>G(M420V)、1426G>A(A476T)和 2401A>C(T801P)的频率分别为 0.002、0.005 和 0.002,已知的 1216G>T(A406S)、1366G>C(V456L)、2495A>G(K832R)、2785A>G(I929V)、2855G>A(R952K)、2871delC(P957PfsX9)、3419T>C(V1140A)、3836A>G(D1279G)、3886G>A(D1296N)和 3889G>A(V1297I)的频率分别为 0.483、0.463、0.387、0.005、0.384、0.005、0.387、0.002、0.012 和 0.015。还分析了检测到的变异之间的连锁不平衡。我们的结果将为日本人群(可能还有其他亚洲人群)中 ATP7A 和 ATP7B 的基因分型提供基础和有用的信息。

相似文献

1
Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients.日本癌症患者中铜和铂类药物外排转运蛋白 ATP7A 和 ATP7B 的遗传多态性。
Drug Metab Pharmacokinet. 2009;24(6):565-74. doi: 10.2133/dmpk.24.565.
2
Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease.威尔逊病基因 K832R 和 R952K 单核苷酸多态性与阿尔茨海默病的关联。
J Alzheimers Dis. 2012;29(4):913-9. doi: 10.3233/JAD-2012-111997.
3
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.铜转运蛋白ATP7A和ATP7B对顺铂及其类似物细胞药理学的调节作用。
Mol Pharmacol. 2004 Jul;66(1):25-32. doi: 10.1124/mol.66.1.25.
4
Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.CTR1、CTR2、ATP7A和ATP7B基因多态性与上皮性卵巢癌铂耐药性的相关性
Int J Clin Pharmacol Ther. 2017 Oct;55(10):774-780. doi: 10.5414/CP202907.
5
The roles of copper transporters in cisplatin resistance.铜转运蛋白在顺铂耐药中的作用。
Cancer Metastasis Rev. 2007 Mar;26(1):71-83. doi: 10.1007/s10555-007-9045-3.
6
The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders.门克斯病和威尔逊病基因在拉布拉多猎犬铜中毒中起拮抗作用:一种新的铜代谢紊乱犬类模型。
Dis Model Mech. 2016 Jan;9(1):25-38. doi: 10.1242/dmm.020263.
7
Thirty novel genetic variations in the SLC29A1 gene encoding human equilibrative nucleoside transporter 1 (hENT1).编码人类平衡核苷转运体1(hENT1)的SLC29A1基因中的30种新的基因变异。
Drug Metab Pharmacokinet. 2006 Jun;21(3):248-56. doi: 10.2133/dmpk.21.248.
8
Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.铜转运体 ATP7B 介导的肿瘤对顺铂耐药的机制。
Biochem Cell Biol. 2011 Apr;89(2):138-47. doi: 10.1139/o10-150.
9
Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.人铜转运ATP 酶 ATP7A 和 ATP7B 对铂类抗癌药物的转运。
Angew Chem Int Ed Engl. 2014 Jan 27;53(5):1297-301. doi: 10.1002/anie.201307718. Epub 2013 Dec 27.
10
Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B.人类铜离子ATP酶ATP7A和ATP7B中的电荷转移机制。
IUBMB Life. 2017 Apr;69(4):218-225. doi: 10.1002/iub.1603. Epub 2017 Feb 5.

引用本文的文献

1
Cuproptosis-Related Gene - and - Polymorphisms are Associated with Risk of Lung Cancer.铜死亡相关基因-和-多态性与肺癌风险相关。
Pharmgenomics Pers Med. 2022 Jul 26;15:733-742. doi: 10.2147/PGPM.S372824. eCollection 2022.
2
ATP7A Clinical Genetics Resource - A comprehensive clinically annotated database and resource for genetic variants in ATP7A gene.ATP7A临床遗传学资源——一个全面的、带有临床注释的ATP7A基因遗传变异数据库和资源。
Comput Struct Biotechnol J. 2020 Sep 2;18:2347-2356. doi: 10.1016/j.csbj.2020.08.021. eCollection 2020.
3
Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.
膀胱癌化疗和放疗耐药的遗传决定因素。
Transl Androl Urol. 2017 Dec;6(6):1081-1089. doi: 10.21037/tau.2017.08.19.
4
Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.非小细胞肺癌中顺铂敏感性的药物基因组学
Genomics Proteomics Bioinformatics. 2014 Oct;12(5):198-209. doi: 10.1016/j.gpb.2014.10.003. Epub 2014 Oct 28.
5
The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.ATP7B基因多态性可预测肺癌患者铂类化疗的临床结局。
Tumour Biol. 2014 Aug;35(8):8259-65. doi: 10.1007/s13277-014-2072-0. Epub 2014 May 23.
6
An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury.一项旨在确定药物基因组学在确定奥沙利铂诱导肝损伤发生中的潜在作用的实验研究。
HPB (Oxford). 2013 Aug;15(8):581-7. doi: 10.1111/hpb.12010. Epub 2012 Dec 27.
7
Polymorphic transporters and platinum pharmacodynamics.多态转运体与铂类药物药效动力学。
Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18.
8
Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.PRPF39 对远端基因的功能影响及顺铂敏感性。
Hum Mol Genet. 2012 Oct 1;21(19):4348-55. doi: 10.1093/hmg/dds266. Epub 2012 Jul 5.
9
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.结直肠癌中的 DNA 损伤反应途径和细胞周期检查点:靶向治疗的当前概念和未来展望。
Curr Cancer Drug Targets. 2012 May;12(4):356-71. doi: 10.2174/156800912800190901.